I'm Andrew Ross Sorkin, co-host of Squatbox along with Joe Kernan and Becky Quick,

and this is Five Things to Know before today's opening bell.

Pfizer winning a bidding war for the obesity drug developer, Metzara.

Now, Metzara is accepting a swooned offer from Pfizer late Friday,

citing U.S. antitrust risks from another bid by Novo Nordisk.

Meantime, shares of Diageo, their hire, the company has appointed the former CEO Friday, citing U.S. antitrust risks from another bid by Novo Nordisk.

Meant, meantime shares of Diageo, they're higher.

The company has appointed the former CEO of UK grocer giant Tesco as its new CEO.

Dave Lewis is going to be taking over at the start of 2026.

And UPS and FedEx grounding their combined fleet now of more than 50 McDonald-D-E MD11 cargo planes that follows that crash of the UPS MD11 in Kentucky last week that killed at least 14 people.

And V's and Mastercard are closing in on a settlement with merchants over credit card interchange fees

after two decades of legal wrangling.

That's according to a Wall Street Journal report.

And the leader and head of news at the BBC resigning amid criticism over the way the news organization

edited a speech by President Trump on January 6, 2021, before protesters stormed the U.S. Capitol.

Critics said the way this speech was edited for a BBC

documentary last year was misleading and removed context.

The, we talked about it at length, that's Sarah. So it's 10 billion. Remember, Pfizer was

at 7.3, no one, and it was done, and they had regulatory approval on everything.

And then Nova Nordisk, Ozempic, they wanted it so badly.

They came in at nine, and people weren't sure whether they could even do it.

And then Pfizer actually matched the sweetened bid from Nova Nord.

...